All News

The AUA Foundation announced that Astellas U.S. has awarded a $1.2 million independent educational grant to continue its support of young academic urologists through the AUA Foundation/Astellas Rising Stars in Urology Award program.

Prostatic artery embolization may be an effective treatment for men suffering from symptoms of an enlarged prostate, researchers said at the Society of Interventional Radiology annual scientific meeting in San Francisco.

Kidney stones in fruit flies may hold the key to developing a treatment that could stop the formation of stones in humans, according to a research team from Mayo Clinic and the University of Glasgow.

A class I histone deacetylase inhibitor, entinostat, has been shown to boost the effectiveness of cancer immunotherapy for treatment of some solid tumors, including kidney and prostate cancer, according to preclinical research by a team from Roswell Park Cancer Institute.

Saying the sustainable growth rate system is fundamentally flawed and has helped erode the confidence of Medicare beneficiaries and physicians alike, the Medicare Payment Advisory Commission is again asking Congress to repeal the SGR and replace it with specified updates no longer based on an expenditure-control formula, as recommended by MedPAC last year.

Effective advocacy depends on data, relationships, and, for lack of a better term, money.

Three urologists share their favorite instrument used in their practices.

Early results from a registry of patients with small renal masses support the safety of active surveillance using a standardized protocol.

Margaret S. Pearle, MD, PhD, discusses the scope of radiation exposure and how to minimize risk from it.

Two additional years of results from the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirm original findings that screening significantly reduces death from prostate cancer.

Jim C. Hu, MD, MPH, will join the UCLA urology faculty in April 2012.

Ohio state Senator Nina Turner (D-Cleveland) recently announced legislation that she says would protect men in Ohio from the risks of phosphodiesterase type-5 inhibitors used to treat erectile dysfunction.

Quest Diagnostics (Madison, NJ) recently announced the availability of a molecular blood test for identifying renal organ-transplant rejection.

Circumcision before a male's first sexual intercourse may help protect against prostate cancer, according to a recent study.

Khurshid Guru, MD, director of the Center for Robotic Surgery at Roswell Park Cancer Institute, Buffalo, NY, has been named the Dr. Robert P. Huben Professor of Urologic Oncology.

Spanish researchers have found that early-onset androgenetic alopecia (AGA) may be a marker of urinary symptoms associated with BPH.

Treatment is still overused in older men with prostate cancer and a short life expectancy, say the authors of a study from Yale School of Medicine, New Haven, CT.

High percentages of radiation oncologists and medical oncologists discuss the impact of cancer treatments on fertility with their patients of childbearing age, but the frequency of these discussions varies widely by specialty, according to a recent study.

Janssen Research & Development, LLC, recently has unblinded the phase III study of the androgen biosynthesis inhibitor abiraterone acetate (ZYTIGA) plus prednisone for the treatment of asymptomatic or mildly symptomatic patients with metastatic castration-resistant prostate cancer (CRPC) who have not received chemotherapy.

Urologic oncologist Steven E. Canfield, MD, has been named chief of the division of urology in the department of surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School.

The FDA recently approved the InTone device (InControl Medical, LLC, Brookfield, WI) to treat female urinary incontinence.

Male fetuses of mothers that are exposed to radiation during early pregnancy may have an increased chance of developing testicular cancer, report researchers from the University of Texas MD Anderson Cancer Center, Houston.

Men receiving testosterone supplementation who also receive the 5-alpha-reductase inhibitor dutasteride (Avodart) do not experience a significant difference in changes in muscle mass, muscle strength, or sexual function compared with men who do not receive dutasteride, according to a recent study.

The AUA has revised its best practice statement on antibiotic prophylaxis for transrectal prostate biopsy to incorporate recent Centers for Medicare & Medicaid Services approval of intramuscular administration of antimicrobials.

Urologists who gathered for the annual Joint Advocacy Conference listened politely as a member of the U.S. Preventive Services Task Force explained the thinking behind the group's recommendation against routine PSA testing, but few, if any of them seemed to have been swayed.

The gene expression analysis of urine sediment could provide a noninvasive way to analyze interstitial cystitis in some patients, according to a recent study.

Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy, report researchers from Thomas Jefferson University?s Kimmel Cancer Center, Philadelphia.

Daily use of long-acting opioids increases the risk of hypogonadism in men compared with those taking short-acting opioids, according to a recent study.